Lenacapavir injection: The new frontier in HIV prevention
Despite its promise, access to Lenacapavir, a revolutionary HIV prevention injection which stops 100% of new HIV infections in women and girls, is restricted.
Lenacapavir offers key HIV treatment advances
A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.
New HIV prevention shot promises six months of protection
An HIV prevention injection that provides six months of protection per shot is highly effective in a pivotal trial largely conducted in South Africa.